Эндоскопическая диагностика состояния желудочно-кишечного тракта у больных лимфомой Ходжкина в процессе химиолучевого лечения. Литературный обзор

Хомов Д.А.; Khomov D.A.

Научные статьи \ Прикладные науки. Медицина. Технология \ Mедицинские науки \ Патология. Клиническая медицина \ Заболевания пищеварительной системы. Болезнь пищеварительного тракта

Эндоскопическая диагностика состояния желудочно-кишечного тракта у больных лимфомой Ходжкина в процессе химиолучевого лечения. Литературный обзор

Автор: Хомов Д.А.

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Обзоры

Статья в выпуске: 1 т.10, 2010 года.

Бесплатный доступ

Состояние желудочно-кишечного тракта на современном этапе развития онкологии изучено в недостаточной степени. Органы желудочно-кишечного тракта, являясь одними из наиболее радио- и химиочувствительных, страдают при применении любой схемы лечения и, если оценка состояния их в процессе лечения и проводится, то только при наличии жалоб пациента. В данной работе предпринята попытка описания эндоскопической картины всего желудочно-кишечного тракта в процессе и после химиолучевого лечения.

Желудочно-кишечный тракт, эндоскопическая диагностика, лимфома ходжкина, химиолучевое лечение

Короткий адрес: https://sciup.org/14955193

IDR: 14955193

Endoscopic diagnostics of changes of gastrointestinal tract in patients with Hodgkin's lymphoma during chemoradiotherapy

The changes of gasrtrointestinal tract caused by anti-tumor treatment have not been studied sufficiently. The organs of gasrtrointestinal tract are highly sensitive to radiation therapy and chemotherapy. They are damaged in every program of therapy for Hodgkin's lymphoma, but those organs are usually examined only if patients haves complaints. The author has attempted to describe endoscopic picture of the whole gasrtrointestinal tract during and after chemoradiotherapy.

Список литературы Эндоскопическая диагностика состояния желудочно-кишечного тракта у больных лимфомой Ходжкина в процессе химиолучевого лечения. Литературный обзор

Байсоголов Г.Д., Шахтарина С.В. Лечение больных лимфогранулематозом III Б стадии//Мед. радиол. и радиац. безоп.-1994.-т.39.-№1.-с.41-46.
Байсоголов Г.Д., Шахтарина С.В., Павлов В.В. Лечение лимфогранулематоза I-IV стадии//Мед. радиол.-1992.-т.37.-№3-4.-с.27-28.
Гершанович М.Л. Осложнения при химио-и гормонотерапии злокачественных опухолей.-М.: Медицина, 1982, 224 с.
Даценко П.В. Расширенная радикальная программа лучевой терапии с профилактическим облучением легких у больных лимфогранулематозом//Диссертация на соискание ученой степени кандидата медицинских наук.-Москва.-1994.
Даценко П.В. Сбалансированное сочетание лучевого и лекарственного компонентов при комплексном лечении лимфогранулематоза. Дисс. д-ра мед. наук.-М.-2004.-235 с.
Демина Е.А. Современное лечение первичных больных лимфомой Ходжкина//VII Росс. онкол. Конгресс.-Москва.-2003.-С.103-108.
Демина Е.А., Ткачев С.И., Трофимова О.П. и др. Комбинированная химиолучевая терапия первичных больных лимфомой Ходжкина//VIII Росс. Онкол. Конгресс.-Москва.-2004.-С.121-125.
Ильин Н.В. Лимфома Ходжкина (болезнь Ходжкина) (лекция, часть I)//Вестник гематологии. -2006. -т.2, №4. -С.51-58.
Ильин Н.В. Лимфома Ходжкина (болезнь Ходжкина) (лекция, часть II)//Вестник гематологии. -2006. -т.3, №1. -С.65-70.
Ильин Н.В., Виноградова Ю.Н. Поздние осложнения терапии больных лимфомой Ходжкина//Практическая онкология. -2007. -т.8 №2. -С.96-101.
Канаев С.В, Гершанович М.Л., Гиршович М.М., Голованов С.Г. Клиническая оценка эффективности химиолучевого лечения лимфомы Ходжкина III стадии//VIII Росс. Онкол. Конгресс.-Москва.-2004.-С.118-120.
Переслегин И.А., Филькова Е.М. Лимфогранулематоз. М., 1980.
Мельник Ю.Д. Новые программы лучевого и лекарственного лечения лимфогранулематоза.//Автореф. дисс. к.м.н., Москва, 2006.
Пробатова Н.А. Морфологические критерии диагностики лимфомы Ходжкина//VI ежегодная Росс. онкол. конф.-Тез. докл.-Москва.-2002.-С. 46 -47.
Тумян Г.С., Тупицин Н.Н, Пробатова Н.А и др. Клиническая и иммуноморфологическая характеристика двух различных форм лимфомы Ходжкина//VI ежегодная Росс. онкол. конф.-Тез. докл.-Москва.-2002.-С. 47 -49.
Харченко В.П., Паньшин Г.А., Сотников В.М., Даценко П.В. Опыт и перспективы расширенной радикальной программы лучевой терапии с профилактическим облучением легких и печени у больных лимфогранулематозом.//Вопр. онкол.-2000.-Т.46.-№6.-С.718-723.
Харченко В.П., Паньшин Г.А., Сотников В.М., Даценко П.В. Роль лучевой терапии в лечении IV стадии болезни Ходжкина//VIII Росс. Онкол. Конгресс.-Москва.-2004.-С.120.
Щербенко О. И., Пархоменко Р.А., Зелинская Н.И., Снигирева Р.Я., Ардатова Г.В., Халиль Е.Ф., Скворцова О.Ю., Сычева Н.А.,Пуртова Г.С., Зуева А.В., Кошкин В.Ф., Снигирев Я.В. Отдаленные последствия химиолучевого лечения лимфогранулематоза у детей//VII Росс. Научн. форум Радиология.-Москва.-2006.-С. 270.
Aisenberg A.C. Problems in Hodgkin's disease management//Blood.-1999.-v.93.-n.3.-p.761-779.
Aleman B.M.P, van den Belt-Dusebout A.W., Klokman W.J., et. al. Late cardiotoxity after treatment for Hodgkin lymphoma.//Blood..-2007.-Vol.109(5). -P.1878-1886.
Aleman B.M., Belt-Dusebout A.W., Klakman W.J. at al. Long-term cause-specific mortality of patients treated for Hodgkin's disease//J.Clin. Oncol. -2003. -Vol.21 -P.3431-3439
Allen-Mersh TG, Wilson EJ, Hope-Stone HFel al. (1986) Has the incidence of radiation-induced bowel damage following treatment of uterine carcinoma changed in the last 20 years?.1 R Soc Med 79: 387 390
Andrieu J.M., Jais J.P., Colonna P., et al. Ten-year results of strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages//Ann Oncol.-1998.-v.9-p.195-203.
Andrieu J.M., Weh H.J., Tiellet F., et al. Localisation pulmonaire de la maladie de Hodgkin. Aspects initiaux et evolution//La Nouv. Presse Med.-1978.-v.7-p.3737-3741.
Anno G.H., Daum S.J., Withers H.R. et al. Symptomatology of acute Radiation Effects in Humans After Exposure to Doses of 0,5-30Gy. Health Physics 1989. -V.56.-N.6. -P.821-838
Aversa S. M., Salvagno L., Soraru M., at al. Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.//Acta Haematol., 2004, v. 112(3), p. 141-147.
Ballova V., Ruffer J.U., Haverkamp H., at al. A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).//Ann Oncol., 2005, v. 16(1), p. 124-31.
Barlett N.L., Rosenberg S.A., Hoppe R.T., et al. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: A preliminary report//J. Clin. Oncol.-1995.-v.13.-p.1080-1088.
Behar R.A., Horning S.J., Hoppe R.T., et al. Hodgkin's disease with bulky mediastinal involvement: Effective management with combined modality therapy//Jnt. J. Radiat Oncol Biol. Phys.-1993.-v.25.-p.771.
Boivin J.F., Hutchison G.B., Lubin J.H., Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease//Cancer.-1992.-v.69-p.1241-1247.
Burger A, Loeffler H, Bamberg M, et al: Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol 73:401-408, 1998
Canellos G. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?//Leukemia.-1996.-v.10.-(Suppl 2).-p.68.
Canellos G., Anderson J., Propert K., et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD//N Eng J Med.-1992.-v.327-p.1478.
Carbone P.P., Kaplan H.S., Musshoff K. et al., Report of the committee on Hodgkin' s disease staging classification.//Cancer Res. -1971. -V.31. -P.1860.
Canellos G.P.,.Lister T.A., Sklar J.L. The Lymphomas, W.B.Saunders Comp. 1998.
Carella A.M., Prencipe E., Pungolino E., et al. Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy//Leukemia and Lymphoma.-1996.-v.21.-N.1-2.-p.63-70
Chittal S. M., Alard C. et al.//Amer. J. Sur. Path., 190, v. 14 (11), p. 1024
Chopra R., McMillan A.K., Linch D.C., et al. The place high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients//Blood.-1993.-v.81.-p.1137
Cosset J.M., Henry-Amar M., Pellae-Cosset B., et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy//Jnt. J. Radiat Oncol. Biol. Phys.-1991.-v.21.-p.447-449.
Canellos G.P.,.Lister T.A., Sklar J.L. The Lymphomas, W.B.Saunders Comp. 1998.
De Vita V.T., Hellman S., Rosenberg S.A. Cancer: Principles Practice of Oncology. 4th Edition.//Philadelphia.-1993.-V.2.-P. 1819-1858.
De Vita V.T., Hellman S., Rosenberg S.A. Cancer: Principles Practice of Oncology. 6th Edition.//Philadelphia: Lippincott-Raven Publishers.-2001.-chapter 45.
Diehl V., Franklin J., Hasenclever D., et al. BEACOPP: A new regimen for advanced Hodgkin's disease//Annals of Oncology. -1998.-v.9.-(Suppl.5).-p.67-71.
Diehl V., Franklin J., Paulus U., et. al. Dose escalated BEACOPP chemotherapy regimen for advanced stage Hodgkin's disease: final analysis of the HD9 randomized trial of the GHSG.//Ann. of Oncology.-2002.-v13.-suppl.2.-p.-25.
Dimitrievich GS, Fischer-Dzoga K, Griem ML: Radiosensitivity of vascular tissue: I-Differential radiosensitivity of capillaries: A quantitative in vivo study. Radiat Res 99:511-535, 1984
Doubleday LC, Bernardino ME (1980) CT findings in the peri-rectal area following radiation therapy. J Comput Assist Tomogr 4: 634-638
DuBrow RA (1994) Radiation changes in the hollow viscera. Semin Roentgenol 29: 38-52
Jaenke RS, Robbins ME, Bywaters T, et al: Capillary endothelium: Target site of renal radiation injury. Lab Invest 68:396-405, 1993
Jaffe E., Harris N., Stein H., Vardiman J.//IACR Press, 2001, Lyon.
Josting A., Wiedenmann S., Franklin J., at al. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.//J. Clin. Oncol., 2003, vol. 21 (18), p. 3440-3446.
Josting A., Behringer K, Engert A, Diehl V. Modern pharmacotherapy of Hodgkin disease.//Internist (Berl), 2004, v. 45(1), p. 93-101.
Economopoulos T., Fountzilas G., Dimopoulos M.A., at al. Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group.//Eur. J. Haematol., 2003, v. 71(4), p. 257-262.
Eich H.T., Muller R.P., Ansen S., at al. New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology//Rontgenpraxis, 2003, v. 55(3), p. 114-24.
Fabian C.J., Mansfield C.M., Dahlberg S., et al. Low-dose involved field radiation after chemotherapy in advanced Hodgkin's disease//Ann Intern Med.-1994.-v.120.-p.903.
Fajardo LF, Bathrong M, Anderson RE: Radiation Pathology. New York, Oxford University Press, 2001
Fishman EK, Zinreich ES, Jones В et al. (1984) Computed! tomographic diagnosis of radiation ileitis. Gastrointest Radiol 9: Р.149-152
Fournier C, Scholz M, Kraft-Weyrather W, et al: Changes of fibrosisrelated parameters after high and low LET irradiation of fibroblasts. Int J Radiat Biol 77:713-722, 2001
Franklin., Diehl V.//Annals of oncology, 1996, v.3, p. 39.
Fuller L.M., Hagemeister F.B., North L.B., et al. The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage I through IIB Hodgkin's disease: Preliminary result//Jnt. J. Radiat. Oncol.-Biol.-Phys.-1988.-Vol.14.-p. 683-692.
Gilinsky NH, Burns DG, Barbezat GO et al. (1983) The natural history of radiation-induced proctosigmoiditis: an analyiss of 88 patients. Q J Med New Series 52: 40-53.
Glick J., Young M., Harrington D., et al. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: The 8-year results of intergroup trial//J. Clin. Oncol. -1998.-v.16.-p.19-26.
Goldstein IIM, Rogers LF, Fletcher GH ct al. (1975) Radiological manifestations of radiation-induced injury to the normal upper gastrointestinal tract. Radiology 117: 135-140
Goldstone A.H. The case for and against high-dose therapy with stem cell rescue for early poor prognosis Hodgkin's disease in first remission//Annals of Oncology.-1998.-v.9.-(Suppl.5).-p.83-85.
Gospodorowicz M.K., Sutcliffe S.B., Clark R.M., et al. Analysis of supradiaphragmatic clinical stages I and II Hodgkin's disease treated with radiation alone//Jnt. J. Radiat Oncol. Biol. Phys.-1992.-v.22.-p.859.Hakenjos L, Bamberg M, Rodemann HP: TGF-_1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic response. Int J Radiat Biol 76:503-509, 2000
Hancock S.L., Hoppe R.T. Long-tern complications of treatment and causes of mortality after Hodgkin's disease//Semin Radiat. Oncol.-1996.-v.6.-p.225
Hauer-Jensen M (1990) Late radiation injury of the small intestine: clinical, pathophysiologic and radiobiologic aspects. ActaOncol 29: 401-415
Henkelmann G.C., Hagemeister F.B., Fuller L.M. Two cycles of MOPP and radiotherapy for stage IIIA and IIIB Hodgkin's disease.//J. Clin. Oncol.-1988.-Vol 6.-P. 1293-1302.Herskind C, Bentzen SM, Overgaard J, et al: Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiother Oncol 47:263-269, 1998
Henry-Amar M. Second cancer after treatment Hodgkin's disease: A report from the International Database on Hodgkin's disease//Ann Oncol.-1992.-v.3.-(Suppl.4).-p.117.
Henry-Amar M., Joly F. Late complications after Hodgkin's disease//Ann Oncol.-1996.-v.7.-(Suppl.4).-p.115.
Herskind C, Johansen J, Bentzen SM, et al: Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy. Acta Oncol 39:383-388, 2000
Hodgkin T. On some morbid appearances of the absorbent glands and spleen//Med-Chir. Trans.-1832.-v.17.-p.68.
Hoppe R.T. Hodgkin's disease: Second cancer after treatment Hodgkin's disease: Complications of therapy and excess mortality//Ann Oncol.-1997.-v.8.-(Suppl.1).-p.115.
Hoppe R.T. Hodgkin's disease: Radiation therapy in the management of Hodgkin's disease//Semin Oncol.-1990.-v.17.-p.704.
Horning S., Rosenberg S., Hoppe R. Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update // Ann Oncol.- 1996.-v.7.-(Suppl.4).-p.105. Hoskin P.J., Smith P., Linch D.C. Late morbidity and survival in early stage Hodgkin's disease treated with involved field or wide field radiotherapy alone.// Ann. of Oncology.- 2002.- v13.-suppl.2.- p.-65.
Jaen J, Santos JA, Carrion JR ct al. (1989) Severe small bowel radiation enteritis. Acta Oncol 28: 717-720
Kaplan H.S. Hodgkin's Disease.//Harvard University Press., Cambridge, Massachusetts, London, England, 1980.
Kanzler H., Kϋppers R., Hansmann M.L. et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 1996, 184, P.1495-1505. Konstantinidou P, Verrou E., Georgio E. et al. Prevalence of hepatitis B in with Hodgkin and non-Hodgkin's lymphomas//Haematologia. -2006.-Vol.91 (Suppl.1).-P.267.
Lara PC, Russell NS, Smolders IJ, et al: Radiation-induced differentiation of human skin fibroblasts: Relationship with cell survival and collagen production. Int J Radiat Biol 70:683-692, 1996
Lee C.K.K., Aeppli D.M., Bloomfield C.D., Levitt S.H. Hodgkin's disease: A reassessment of prognostic factors following modification of radiotherapy//Int. J. Radiat. Oncol.-Biol.-Phys.-1987.-Vol.13.-p. 983-991.
Lee KH, Kagan AR, Nussbaum II et al. (1976) Analysis of dose, dose-rate and treatment time in production of injuries by radiation treatment for cancer of the uterine cervix. Br J Radiol 49: 430-440
Lеpke RA, Libshitz HI (1983) Radiation-induced injury of the esophagus. Radiology 48: 375-378
Levis A., Gobbi P.G., Chisesi T. ABVD vs. Stanford vs. MOPP-EVP-CAD in advanced Hodgkin's lymphoma. Results of randomized trial.//Ann. of Oncology.-2002.-v13.-suppl.2.-p.-25.
Levitt S.H., Lee C.K.K. Dilemmas and decisions//"Int. J. Radiat. Oncol. Biol. Phys.".-1990.-V. 18.-P. 485-488.
Loeffler M., Hasenclever D., Sextro M., et al. For the International Database on Hodgkin's disease Overview Study Group: Meta-analysis of chemotherapy versus combined treatment trials in Hodgkin's disease//J. Clin. Oncol.-1998.-v.16.-p.818.
Longo D.L. The case against the routine use of radiation therapy in advanced stage Hodgkin's disease//Cancer invest.-1996.-v.14.-p.353.
Longo D.L., Glatstein E., Duffey P.L., et al. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease//J. Clin. Oncol.-1997.-v.15.-N.11.-p.3338-3346.
Longo D.L., Russo A., Duffey P.L., et al. Treatment of advanced stage massive mediastinal Hodgkin's disease: The cases for combined modality treatment//J. Clin. Oncol.-1991.-v.9.-p.227
Mameghan H, Fisher R, Mameghan J el al. (1990) Bowel complications alter radiotherapy for carcinoma of the prostate: the volume effect. Int J Radiat Oncol Biol Phys 18: 315-320
Martinelli G., Cocorocchio E, Peccatori F, at al. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis//Br. J. Haematol., 2004, v. 125(5), p. 584-899.
Mathe G., Rappaport H., O'Connor G.T., et al. Histological and cytological typing of neoplastic disease of hematopoietic and lymphoid tissuers/In: WHO International Histological Classification of Tumors.-Geneva: WHO, 1976.-N14.
Mauch P.M. Controversies in the management of early stage Hodgkin's disease//Blood.-1994.-v.83.-p.319.
Mauch P.M. Management of early stage Hodgkin's disease: The role of radiation therapy and/or chemotherapy//Ann Oncol.-1996.-v.7.-(Suppl.4).-p.79.
Mauch P.M., Kalish L.A., Marcus K.S., et al. Long-term survival in Hodgkin's disease: Relative impact of mortality, second tumors, infection and cardiovascular disease//Cancer J. Sci. Am.-1995.-v.1.-p.33
Mauch P.V., Armitage J.D., Diehl V., et al. Hodgkin's disease//Philadelphia.-1999
Mason GR, Dietrich P, Friedland GW et al. (1970) The radiological findings in radiation-induced enteritis and colitis: a review of 30 cases. Clin Radiol 21: 232-247
Mendelson RM, Nolan DJ (19.85) The radiological features of chronic radiation enteritis. Clin Radiol 36:141-148
Meyer JE (1981) Radiography of the distal colon and rectum after irradiation of carcinoma of the cervix. AJR 136: 691-699
Mendenhall N.P., Lynch J.W., Jr'Bennet C.J. Is combined modality therapy necessary for advanced Hodgkin's disease?//Jnt. J. Radiat Oncol. Biol. Phys.-1997.-v.38.-N.3.-p.583-592
Mogavero GT, Jones B, Cameron JL et al. (1992) Gastric and duodenal obstruction in patients with cholangiocarcinoma in the porta hepatis: increased prevalence after radiation therapy. AJR 159: 1001-1003
Morris GM, Coderre JA, Bywaters A, et al: Boron neutron capture irradiation of the rat spinal cord: Histopathological evidence of a vascularmediated pathogenesis. Radiat Res 146:313-320, 1996
Mundt A.J., Sibley G., Williams S., et al. Pattern of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease//Jnt. J. Radiat Oncol. Biol. Phys.-1995.-v.33.-N.2.-p.261-270.
Pavlovsky S., Santarelli M.T., Sackmann F., et al. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV Hodgkin's disease//Ann Oncol.-1992.-v.3.-p.533
Peter Rodemann, Marcel A. Blaese Responses of Normal Cells to Ionizing Radiation//Radiation oncology. -2007.-P81
Pena LA, Fuks Z, Kolesnick R: Stress-induced apoptosis and the sphingomyelinpathway. Biochem Pharmacol 53:615-621, 1997
Pena LA, Fuks Z, Kolesnick RN: Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 60:321-327, 2000
Peters V. A study of survival in Hodgkin's disease treated by irradiation//Am. J. Roent.-1950.-v.63.-p.299-311.
Phillips TL, Fu KK (1976) Quantification of combined radiation therapy and chemotherapy effects on critical normal tissue. Cancer 37:1186-1200
Polish RA, Boen J, Jones TK et al. (1981) Probability models in the analysis of radiation-related complications: utility and limitations. Radiology 140: 203-207
Prosnitz L.R., Curtis A.M., Knowlton A.H., et al. Supradiaphragmatic Hodgkin's disease: Significance of large mediastinal masses//Jnt. J. Radiat Oncol. Biol. Phys.-1980.-v.6.-p.809.
Prosnitz L.R., Farber L.R., Kapp D.S., et al. Combined modality therapy necessary for advanced stage Hodgkin's disease: 15-year follow-up data//J. Clin Oncol.-1988.-v.6.-N.6.-p.603-612.
Prosnitz L.R., Wu J.J., Yahalom J. The case for adjuvant radiation therapy in advanced Hodgkin's disease//Cancer Invest.-1996.-v.14.-p.361.
Radford J.A., Cowan R.A., Ryder W.D.J. Four weeks of VAPEC-B chemotherapy before involved field radiotherapy minimizes the relapse rate in early stage, low risk Hodgkin's disease and is not associated with an excess of second malignancy.//Ann. of Oncology.-2002.-v13.-suppl.2.-p.-25.
Raemaekers J., Burgers M., Henry-Amar M., et al. Patients with Stage III/IV Hodgkin's Disease in Partial Remission after MOPP/ABV Chemotherapy Have Excellent Prognosis after Additional Involved Field Radiotherapy: Interim Results from the Ongoing EORTC LCG and GPMC Phase III Trial//Ann Oncol.-1996.-v.7.-(Suppl.3).-p.22.-a.070.
Rodemann HP, Bamberg M: Cellular basis of radiation-induced fibrosis. Radiother Oncol 35:83-90, 1995
Rodemann HP, Peterson HP, Schwenke K, et al: Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc 5:1135-1143, 1992
Rodemann HP, Binder A, Burger A, et al: The underlying cellular mechanism of fibrosis. Kidney Int 49:32-36, 1996
Rodemann HP, Bayreuther K, Francz PI, et al: Selective enrichment and biochemical characterisation of seven fibroblast cell types of human skin fibroblast populations in vitro. Exp Cell Res 180:84-93, 1989
Rubin P, Finkelstein J, Schapiro D: Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: Interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys 24:93-101, 1992
Stein H., Diehl V., Marafioti T. et al.//The nature of Reed-Sternberg cells, lymphocytic and histiocytic cells and their molecular biology in Hodgkin"s Disease/In: Hodgkin"s Disease, Mauch P., Armitage J.O., Diehl V.(eds).-Lippincott Williams & Wilkins: Philadelphia.-1999.-P.121.
Sextro M., Diehl V., Franklin I., et al.//Ann. Oncol., 1996, v. 7, p. 61.
Sextro M., Lieberz D., Franklin I., et al. For the German Hodgkin's Lymphoma Study Group (GHSG). Liver involvement in Hodgkin's lymphoma: An analysis of 94 consecutive cases//Blood.-1996.-v.88.-(Suppl.1).-p.227a.-(a896).
Sieber M., Franklin J., Bredenfeld H., et. al. Assessment of a 14 day variant of the BEACOPP regimen in advanced Hodgkin's Disease: results of pilot-study of the German Hodgkin's Lymphoma Study Group (GHSG).//Ann. of Oncology.-2002.-v13.-suppl.2.-p.-63.
Steward J.R., Fajardo L.F., Gillette S.M., Constine L.S. Radiation injury to the heart//Jnt. J. Radiat Oncol. Biol. Phys.-1995.-v.31.-p.1205.
Steel G.G. (ed.) Basic Clinical Radiobiology, Third edition, Hodder Arnold, 2002, 262 P.
Strup-Perrot C, Vozenin-Brotons MC, Vandamme M, et al: Expression and activation of MMP-2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation. Scand J Gastroenterol. 41:60-70, 2006
Swerdlow A.J., Douglas A.J., Vaughan Hudson G., et al. Risk of second primary cancer of Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation//Br Med J. -1992.-v.304.-p.1137.
Tada H, Ogushi F, Tani K, et al: Increased binding of chemotactic capacities of PDGF-BB on fibroblasts in radiation pneumonitis. Radiat Res 159:805-811, 2003
Taylor PM, Johnson RJ, Eddleston В et al. (1990) Radiological changes in the gastrointestinal and genitourinary tract follow ing radiotherapy for carcinoma of the cervix. Clin Radiol 41:165-169
Travis E.L. Genetic Susceptibility To Late Normal Tissue Injury. Sem Radiation Oncology. 2007. V.17. -P.149-155
Van Leeuwenl F.E., Klokman W.J., Hagenbeek A., et al. Second cancer risk following Hodgkin's disease: A 20-year follow-up study//J Clin Oncol.-1994.-v.12.-p.312.
WHO Handbook for Reporting Results of Cancer Treatment.-Geneva, 1979.-Vol.48
Wolf J., Diehl V. Hodgkin's disease -pathogenesis and therapy//Ther. Umsch.-1996.-v.53.-N.2.-p.140-146.
Yahalom J., Ryu J., Straus J., et al. Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations//J Clin Oncol.-1991.-v.9.-p.2193-2201.
Yabalom J. Principles, Indications, and Techniques of Radiation Therapy of Lymphomas/The Lymphomas (Second Edition) Ed. By: Canellos G., Lister T.A., Yaung B. -2006. -P.203-224.
Yeoh E, Horowitz M (1988) Radiation enteritis. Br J Hosp Mevv 39:498-504
Young R.C., Canellos G.P., Chabner B.A., et al. Patterns of relapse in Hodgkin's disease treated with combination chemotherapy//Cancer.-1978.-v.42.-p.1001-1007
Yuhasz M, Laufcr I, Sutton G et al. (1985) Radiography of the small bowel in patients with gynecologic malignancies. AJR 144:303-307
Zekri J.M., Mouncey P, Hancock BW. Trials in Advanced Hodgkin's Disease: More than 30 Years Experience of the British National Lymphoma Investigation.//Clin. Lymphoma., 2004, v. 5(3), p. 174-183.

Еще